Alpa Laboratories Ltd
Alpa Laboratories Ltd (ALPA) last traded at ₹61.5, a market capitalisation of ₹129 crore, on a P/E of 31.9. Over the past 52 weeks the stock has ranged between ₹46 and ₹100. Alpa Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹23.93 crore and net profit of ₹0.98 crore. Figures are as of 25 Aug 2026 and are not real time.
Alpa Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Alpa Laboratories Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹23.93 cr, up 25.2% from ₹19.11 cr a year earlier. Net profit was ₹0.98 cr, down 91.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 24.94 | 26.15 | 39.92 | 19.11 | 26.26 | 29.05 | 31.4 | 23.93 |
| Expenses | 21.62 | 25.41 | 39.72 | 18.68 | 28.51 | 27.54 | 27.8 | 27.89 |
| Operating profit | 3.32 | 0.74 | 0.2 | 0.43 | -2.25 | 1.51 | 3.6 | -3.96 |
| OPM % | 13.31% | 2.83% | 0.50% | 2.25% | -8.57% | 5.20% | 11.46% | -16.55% |
| Other income | 6.91 | 8.8 | 2.48 | 11.94 | 3.06 | 0.91 | -0.16 | 5.77 |
| Interest | 0.05 | 0.09 | 0.02 | 0.05 | 0.03 | 0.03 | 0.15 | 0.11 |
| Depreciation | 0.53 | 0.55 | 0.58 | 0.55 | 0.67 | 0.65 | 0.22 | 0.72 |
| Profit before tax | 9.65 | 8.9 | 2.08 | 11.77 | 0.11 | 1.74 | 3.07 | 0.98 |
| Tax % | 20.31% | 0.00% | 201.92% | 0.00% | 0.00% | 9.20% | 55.05% | 0.00% |
| Net profit | 7.69 | 8.9 | -2.12 | 11.77 | 0.11 | 1.59 | 1.38 | 0.98 |
| EPS (₹) | 3.65 | 4.23 | -1.01 | 5.59 | 0.05 | 0.76 | 0.66 | 0.47 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Alpa Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 97 | 112 | 93 | 109 | 110 | 106 | 111 |
| Operating profit | 8 | 11 | 8 | 9 | 5 | 3 | -1 |
| OPM % | 8% | 10% | 9% | 8% | 4.4% | 3.1% | -1.0% |
| Net profit | 7 | 14 | 13 | 17 | 20 | 15 | 4 |
| EPS (₹) | 3.45 | 6.70 | 5.98 | 7.98 | 9.27 | 7.13 | 1.94 |
TTM is the trailing twelve months to the most recent quarter.
Alpa Laboratories Ltd growth and returns
- 10 Years
- 7%
- 5 Years
- 2%
- 3 Years
- 4%
- TTM
- 0%
- 10 Years
- 8%
- 5 Years
- 24%
- 3 Years
- 6%
- TTM
- -85%
- 10 Years
- 7%
- 5 Years
- 3%
- 3 Years
- -9%
- 1 Year
- -37%
- 10 Years
- 7%
- 5 Years
- 10%
- 3 Years
- 11%
- Last Year
- 8%
Alpa Laboratories Ltd shareholding pattern
Promoters held 57.19% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.35% and DIIs 0.07%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.19% | 57.19% |
| FIIs | 0.74% | 0.35% | 0.40% | 0.36% | 0.35% | 0.36% | 0.38% | 0.35% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.07% |
| Public | 41.97% | 42.34% | 42.30% | 42.34% | 42.36% | 42.35% | 42.43% | 42.38% |
| No. of shareholders | 18,885 | 19,206 | 18,872 | 18,851 | 18,542 | 18,236 | 17,900 | 17,643 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Alpa Laboratories Ltd corporate filings
- Results for the quarter ended June 2026 along with the approval of Notice of 38th Annual General MeetingResulthigh impact
Cruxal's analysis: Alpa Laboratories Ltd. reported a sharp decline in financial performance for the quarter…
Read the full analysis - CLARIFICATION ON BOARD MEETING DATE WITH RESPECT TO THE EARLIER SUBMISSIONCompany Updatelow impact
Cruxal's analysis: Alpa Laboratories Ltd. has issued a formal clarification regarding a typographical error…
Read the full analysis - Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Standalone and Consolidated ....Board Meetinglow impact
Cruxal's analysis: Alpa Laboratories Ltd. has announced that its Board of Directors will convene on…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Alpa Laboratories Ltd
Cruxal reads every Alpa Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.